ANDREW STONE: Open Payments
NPI 1538108857 · NORTH PROVIDENCE, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,004 in 130 payments from 23 companies in 2025. Trend: 2023 $0 · 2024 $964 · 2025 $3,004
Food & beverage: $2,904Education: $100
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 22 | $540 |
| GlaxoSmithKline, LLC. | 24 | $518 |
| Grifols USA, LLC | 14 | $302 |
| Mallinckrodt Hospital Products Inc. | 8 | $254 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $199 |
| Verona Pharma, Inc. | 9 | $171 |
| GENZYME CORPORATION | 5 | $136 |
| Merck Sharp & Dohme LLC | 4 | $120 |
| Regeneron Healthcare Solutions, Inc. | 5 | $117 |
| ANI Pharmaceuticals, Inc. | 4 | $96 |
Products named: Prolastin-C Liquid, TRELEGY ELLIPTA, TEZSPIRE, ACTHAR, DUPIXENT, FASENRA, NUCALA, Ohtuvayre.
Industry payments across RI — which companies pay providers there.
